KISHORE KHOT: Open Payments
NPI 1568573038 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,872 in 190 payments from 13 companies in 2025. Trend: 2023 $1,465 · 2024 $1,265 · 2025 $6,872
Consulting: $3,680Food & beverage: $3,183Education: $9
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $3,961 |
| ABBVIE INC. | 41 | $710 |
| Alkermes, Inc. | 26 | $477 |
| Neurocrine BioSciences, Inc. | 18 | $335 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $312 |
| Teva Pharmaceuticals USA, Inc. | 15 | $249 |
| Otsuka America Pharmaceutical, Inc. | 13 | $239 |
| Vanda Pharmaceuticals Inc. | 16 | $195 |
| Janssen Pharmaceuticals, Inc | 10 | $165 |
| Lundbeck LLC | 6 | $121 |
Products named: VRAYLAR, ARISTADA, INGREZZA, CAPLYTA, COBENFY, REXULTI, UZEDY, FANAPT.
Industry payments across MO — which companies pay providers there.
